Histopathology of resected myocardium and outcome of partial left ventriculectomy

A T Kawaguchi1, H Ishibashi-Ueda, J Bergsland

  • 1Tokai University School of Medicine, Isehara, Kanagawa, Japan. akira@is.icc.u-tokai.ac.jp

Journal of Cardiac Surgery
|November 21, 2001
PubMed
Abstract

Insights

Myocardial interstitial fibrosis, not hemodynamics, predicts outcomes after partial left ventriculectomy (PLV). Less hypertrophy and fibrosis correlate with better survival, suggesting fibrosis assessment for patient selection.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Pathology

Background:

  • Preoperative hemodynamics are not established predictors for partial left ventriculectomy (PLV) outcomes.
  • Myocardial histopathology may offer better correlation with PLV efficacy and patient survival.

Purpose of the Study:

  • To investigate the correlation between myocardial histopathology and postoperative survival in patients undergoing PLV.
  • To determine if myocyte size, interstitial fibrosis, endocardial fibrosis, or inflammatory cell infiltration predict outcomes after PLV.

Main Methods:

  • Assessed myocyte size, endocardial fibrosis, interstitial fibrosis, and inflammatory cell infiltration in 338 patients undergoing PLV.
  • Correlated histopathological findings with postoperative survival rates.

Main Results:

  • Advanced interstitial fibrosis (> or = moderate) was associated with reduced survival (p = 0.064 overall, p = 0.0039 for nonischemic etiology).
  • Endocardial fibrosis did not correlate with survival, while severe inflammation in Chagas' disease correlated with poor survival.
  • Patients with less myocyte hypertrophy (< 30 micron) showed a tendency toward increased survival (p = 0.067).

Conclusions:

  • Interstitial fibrosis is a key factor for stratifying patients for PLV versus transplantation.
  • PLV may be more advantageous in patients with less hypertrophy and before significant interstitial fibrosis develops.
  • Endomyocardial biopsy may not fully capture interstitial fibrosis; metabolic or perfusion studies might be better for assessing myocardial histopathology and viability.

Related Concept Videos